HerMD is on a mission to close the gender gap in health care.
Women make up half of the world’s population, yet, only 1% of the $200B spent on healthcare research to improve treatment solutions goes toward women’s health. Yes, that’s right.
Another fact: there are only 2 FDA-approved medications for hypoactive sexual desire disorder (HSDD or low libido), while men have 26 for erectile dysfunction alone. With research, we can start to close the gender gap in health care and give women more FDA-approved treatment options that are covered by insurance, making them more cost-effective and finally making treatment options more accessible to more people.
Interested in partnering with us on a research trial to advance women’s health care?
Our Clinical Research
Botulinum Toxin (Botox®) for the Treatment of Vaginismus
Improving Symptoms Associated with Sexual Health and Menopause Conditions
Utilizing Advanced, Innovative Technologies To
Fractional CO2 laser treatment
as adjunctive therapy to topical steroids for managing vulvar lichen sclerosus.
Evaluation of flibanserin’s benefits
and tolerability in women with low libido and a history of breast cancer.